Interleukin 17 Production Among Patients with American Cutaneous Leishmaniasis

Citation

Olívia Bacellar, Daniela Faria, Márcia Nascimento, Thiago M. Cardoso, Kenneth J. Gollob, Walderez O. Dutra, Phillip Scott, Edgar M. Carvalho, Interleukin 17 Production among Patients with American Cutaneous Leishmaniasis, The Journal of Infectious Diseases, Volume 200, Issue 1, 1 July 2009, Pages 75–78, https://doi.org/10.1086/599380

Abstract

Interleukin 17 (IL-17) plays a critical role in inflammation and autoimmunity. Very little is known about IL-17 in protozoa infection. Here, we show that lymphocytes obtained from patients with mucosal leishmaniasis and cutaneous leishmaniasis produce higher levels of IL-17 than do lymphocytes obtained from uninfected control subjects (⁠P<.01⁠). There was a tendency for tissue obtained from patients with mucosal leishmaniasis to contain a higher number of cells expressing IL-17, compared with tissue obtained from patients with cutaneous leishmaniasis, and there was a direct correlation between the number of cells expressing IL-17 and the presence of cellular inflammation at the lesion site (⁠r2=0.86⁠; P<.001⁠). These data support the role of IL-17 in the pathogenesis of the inflammatory reaction in leishmaniasis.

Keywords: inflammation, cutaneous leishmaniasis, autoimmunity, interleukin-17, leishmaniasis, lymphocytes, infections, protozoa, mucosal leishmaniasis


Read more from SRI

  • Banner and attendees at the IEEE Hard Tech Venture Summit

    Cultivating hard tech startups that scale

    IEEE’s Hard Tech Venture Summit convened innovators at SRI to refine strategies and build new networks.

  • Patient going into a MRI

    Bringing surgical tools inside the MRI

    Drawing on SRI’s unique innovation ecosystem, the startup Medical Devices Corner is seeking to improve cancer surgery by advancing MRI-safe teleoperation.

  • Christopher Mims and Susan Patrick

    PARC Forum: How to AI

    The Wall Street Journal tech columnist Christopher Mims and SRI Education’s Susan Patrick discuss how AI can strengthen human agency.